Report Detail

Medical Devices & Consumables Global Needle-free Injection Systems Supply, Demand and Key Producers, 2026-2032

  • RnM4669218
  • |
  • 22 January, 2026
  • |
  • Global
  • |
  • 152 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

The global Needle-free Injection Systems market size is expected to reach $ 333 million by 2032, rising at a market growth of 5.0% CAGR during the forecast period (2026-2032).
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Global Needle-free Injection Systems main manufactuers Antares Pharma, Endo International plc and Inovio Pharmaceuticals, which totally accounts for the 65% of the market. As for the types of products, it can be divided into Powder Injections, Liquid Injections and Depot or Projectile Injection. In terms of application, it is widely used in SVaccine Delivery, Insulin Delivery and Others. The most common application is Insulin Delivery, with a share over 56%.
This report studies the global Needle-free Injection Systems production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Needle-free Injection Systems and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Needle-free Injection Systems that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Needle-free Injection Systems total production and demand, 2021-2032, (K Units)
Global Needle-free Injection Systems total production value, 2021-2032, (USD Million)
Global Needle-free Injection Systems production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Needle-free Injection Systems consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Needle-free Injection Systems domestic production, consumption, key domestic manufacturers and share
Global Needle-free Injection Systems production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Needle-free Injection Systems production by Power, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Needle-free Injection Systems production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Needle-free Injection Systems market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Antares Pharma, Endo International plc, Inovio Pharmaceuticals, Injex Pharma, National Medical Products Inc (J-Tip), Recipharm, European Pharma Group (InsuJet), Miracle Medical, Medical International Technology (MIT), Akra Dermojet, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Needle-free Injection Systems market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Power, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Needle-free Injection Systems Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Needle-free Injection Systems Market, Segmentation by Power:
Reusable Injector
Single-use Injector
Global Needle-free Injection Systems Market, Segmentation by Application:
Vaccine Delivery
Insulin Delivery
Others
Companies Profiled:
Antares Pharma
Endo International plc
Inovio Pharmaceuticals
Injex Pharma
National Medical Products Inc (J-Tip)
Recipharm
European Pharma Group (InsuJet)
Miracle Medical
Medical International Technology (MIT)
Akra Dermojet
PharmaJet
Portal Instruments
Crossject Medical Technology
MIKA MEDICAL
Ferring Pharmaceuticals
D'Antonio Consultants International
Lepu Medical
TECHiJET
Key Questions Answered:
1. How big is the global Needle-free Injection Systems market?
2. What is the demand of the global Needle-free Injection Systems market?
3. What is the year over year growth of the global Needle-free Injection Systems market?
4. What is the production and production value of the global Needle-free Injection Systems market?
5. Who are the key producers in the global Needle-free Injection Systems market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Needle-free Injection Systems Introduction
  • 1.2 World Needle-free Injection Systems Supply & Forecast
    • 1.2.1 World Needle-free Injection Systems Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Needle-free Injection Systems Production (2021-2032)
    • 1.2.3 World Needle-free Injection Systems Pricing Trends (2021-2032)
  • 1.3 World Needle-free Injection Systems Production by Region (Based on Production Site)
    • 1.3.1 World Needle-free Injection Systems Production Value by Region (2021-2032)
    • 1.3.2 World Needle-free Injection Systems Production by Region (2021-2032)
    • 1.3.3 World Needle-free Injection Systems Average Price by Region (2021-2032)
    • 1.3.4 North America Needle-free Injection Systems Production (2021-2032)
    • 1.3.5 Europe Needle-free Injection Systems Production (2021-2032)
    • 1.3.6 South Korea Needle-free Injection Systems Production (2021-2032)
    • 1.3.7 China Needle-free Injection Systems Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Needle-free Injection Systems Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Needle-free Injection Systems Major Market Trends

2 Demand Summary

  • 2.1 World Needle-free Injection Systems Demand (2021-2032)
  • 2.2 World Needle-free Injection Systems Consumption by Region
    • 2.2.1 World Needle-free Injection Systems Consumption by Region (2021-2026)
    • 2.2.2 World Needle-free Injection Systems Consumption Forecast by Region (2027-2032)
  • 2.3 United States Needle-free Injection Systems Consumption (2021-2032)
  • 2.4 China Needle-free Injection Systems Consumption (2021-2032)
  • 2.5 Europe Needle-free Injection Systems Consumption (2021-2032)
  • 2.6 Japan Needle-free Injection Systems Consumption (2021-2032)
  • 2.7 South Korea Needle-free Injection Systems Consumption (2021-2032)
  • 2.8 ASEAN Needle-free Injection Systems Consumption (2021-2032)
  • 2.9 India Needle-free Injection Systems Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Needle-free Injection Systems Production Value by Manufacturer (2021-2026)
  • 3.2 World Needle-free Injection Systems Production by Manufacturer (2021-2026)
  • 3.3 World Needle-free Injection Systems Average Price by Manufacturer (2021-2026)
  • 3.4 Needle-free Injection Systems Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Needle-free Injection Systems Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Needle-free Injection Systems in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Needle-free Injection Systems in 2025
  • 3.6 Needle-free Injection Systems Market: Overall Company Footprint Analysis
    • 3.6.1 Needle-free Injection Systems Market: Region Footprint
    • 3.6.2 Needle-free Injection Systems Market: Company Product Type Footprint
    • 3.6.3 Needle-free Injection Systems Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Needle-free Injection Systems Production Value Comparison
    • 4.1.1 United States VS China: Needle-free Injection Systems Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Needle-free Injection Systems Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Needle-free Injection Systems Production Comparison
    • 4.2.1 United States VS China: Needle-free Injection Systems Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Needle-free Injection Systems Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Needle-free Injection Systems Consumption Comparison
    • 4.3.1 United States VS China: Needle-free Injection Systems Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Needle-free Injection Systems Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Needle-free Injection Systems Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Needle-free Injection Systems Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Needle-free Injection Systems Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Needle-free Injection Systems Production (2021-2026)
  • 4.5 China Based Needle-free Injection Systems Manufacturers and Market Share
    • 4.5.1 China Based Needle-free Injection Systems Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Needle-free Injection Systems Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Needle-free Injection Systems Production (2021-2026)
  • 4.6 Rest of World Based Needle-free Injection Systems Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Needle-free Injection Systems Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Needle-free Injection Systems Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Needle-free Injection Systems Production (2021-2026)

5 Market Analysis by Power

  • 5.1 World Needle-free Injection Systems Market Size Overview by Power: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Power
    • 5.2.1 Reusable Injector
    • 5.2.2 Single-use Injector
  • 5.3 Market Segment by Power
    • 5.3.1 World Needle-free Injection Systems Production by Power (2021-2032)
    • 5.3.2 World Needle-free Injection Systems Production Value by Power (2021-2032)
    • 5.3.3 World Needle-free Injection Systems Average Price by Power (2021-2032)

6 Market Analysis by Application

  • 6.1 World Needle-free Injection Systems Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Vaccine Delivery
    • 6.2.2 Insulin Delivery
    • 6.2.3 Others
  • 6.3 Market Segment by Application
    • 6.3.1 World Needle-free Injection Systems Production by Application (2021-2032)
    • 6.3.2 World Needle-free Injection Systems Production Value by Application (2021-2032)
    • 6.3.3 World Needle-free Injection Systems Average Price by Application (2021-2032)

7 Company Profiles

  • 7.1 Antares Pharma
    • 7.1.1 Antares Pharma Details
    • 7.1.2 Antares Pharma Major Business
    • 7.1.3 Antares Pharma Needle-free Injection Systems Product and Services
    • 7.1.4 Antares Pharma Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Antares Pharma Recent Developments/Updates
    • 7.1.6 Antares Pharma Competitive Strengths & Weaknesses
  • 7.2 Endo International plc
    • 7.2.1 Endo International plc Details
    • 7.2.2 Endo International plc Major Business
    • 7.2.3 Endo International plc Needle-free Injection Systems Product and Services
    • 7.2.4 Endo International plc Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Endo International plc Recent Developments/Updates
    • 7.2.6 Endo International plc Competitive Strengths & Weaknesses
  • 7.3 Inovio Pharmaceuticals
    • 7.3.1 Inovio Pharmaceuticals Details
    • 7.3.2 Inovio Pharmaceuticals Major Business
    • 7.3.3 Inovio Pharmaceuticals Needle-free Injection Systems Product and Services
    • 7.3.4 Inovio Pharmaceuticals Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Inovio Pharmaceuticals Recent Developments/Updates
    • 7.3.6 Inovio Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.4 Injex Pharma
    • 7.4.1 Injex Pharma Details
    • 7.4.2 Injex Pharma Major Business
    • 7.4.3 Injex Pharma Needle-free Injection Systems Product and Services
    • 7.4.4 Injex Pharma Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Injex Pharma Recent Developments/Updates
    • 7.4.6 Injex Pharma Competitive Strengths & Weaknesses
  • 7.5 National Medical Products Inc (J-Tip)
    • 7.5.1 National Medical Products Inc (J-Tip) Details
    • 7.5.2 National Medical Products Inc (J-Tip) Major Business
    • 7.5.3 National Medical Products Inc (J-Tip) Needle-free Injection Systems Product and Services
    • 7.5.4 National Medical Products Inc (J-Tip) Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 National Medical Products Inc (J-Tip) Recent Developments/Updates
    • 7.5.6 National Medical Products Inc (J-Tip) Competitive Strengths & Weaknesses
  • 7.6 Recipharm
    • 7.6.1 Recipharm Details
    • 7.6.2 Recipharm Major Business
    • 7.6.3 Recipharm Needle-free Injection Systems Product and Services
    • 7.6.4 Recipharm Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Recipharm Recent Developments/Updates
    • 7.6.6 Recipharm Competitive Strengths & Weaknesses
  • 7.7 European Pharma Group (InsuJet)
    • 7.7.1 European Pharma Group (InsuJet) Details
    • 7.7.2 European Pharma Group (InsuJet) Major Business
    • 7.7.3 European Pharma Group (InsuJet) Needle-free Injection Systems Product and Services
    • 7.7.4 European Pharma Group (InsuJet) Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.7.5 European Pharma Group (InsuJet) Recent Developments/Updates
    • 7.7.6 European Pharma Group (InsuJet) Competitive Strengths & Weaknesses
  • 7.8 Miracle Medical
    • 7.8.1 Miracle Medical Details
    • 7.8.2 Miracle Medical Major Business
    • 7.8.3 Miracle Medical Needle-free Injection Systems Product and Services
    • 7.8.4 Miracle Medical Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.8.5 Miracle Medical Recent Developments/Updates
    • 7.8.6 Miracle Medical Competitive Strengths & Weaknesses
  • 7.9 Medical International Technology (MIT)
    • 7.9.1 Medical International Technology (MIT) Details
    • 7.9.2 Medical International Technology (MIT) Major Business
    • 7.9.3 Medical International Technology (MIT) Needle-free Injection Systems Product and Services
    • 7.9.4 Medical International Technology (MIT) Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.9.5 Medical International Technology (MIT) Recent Developments/Updates
    • 7.9.6 Medical International Technology (MIT) Competitive Strengths & Weaknesses
  • 7.10 Akra Dermojet
    • 7.10.1 Akra Dermojet Details
    • 7.10.2 Akra Dermojet Major Business
    • 7.10.3 Akra Dermojet Needle-free Injection Systems Product and Services
    • 7.10.4 Akra Dermojet Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Akra Dermojet Recent Developments/Updates
    • 7.10.6 Akra Dermojet Competitive Strengths & Weaknesses
  • 7.11 PharmaJet
    • 7.11.1 PharmaJet Details
    • 7.11.2 PharmaJet Major Business
    • 7.11.3 PharmaJet Needle-free Injection Systems Product and Services
    • 7.11.4 PharmaJet Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.11.5 PharmaJet Recent Developments/Updates
    • 7.11.6 PharmaJet Competitive Strengths & Weaknesses
  • 7.12 Portal Instruments
    • 7.12.1 Portal Instruments Details
    • 7.12.2 Portal Instruments Major Business
    • 7.12.3 Portal Instruments Needle-free Injection Systems Product and Services
    • 7.12.4 Portal Instruments Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.12.5 Portal Instruments Recent Developments/Updates
    • 7.12.6 Portal Instruments Competitive Strengths & Weaknesses
  • 7.13 Crossject Medical Technology
    • 7.13.1 Crossject Medical Technology Details
    • 7.13.2 Crossject Medical Technology Major Business
    • 7.13.3 Crossject Medical Technology Needle-free Injection Systems Product and Services
    • 7.13.4 Crossject Medical Technology Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.13.5 Crossject Medical Technology Recent Developments/Updates
    • 7.13.6 Crossject Medical Technology Competitive Strengths & Weaknesses
  • 7.14 MIKA MEDICAL
    • 7.14.1 MIKA MEDICAL Details
    • 7.14.2 MIKA MEDICAL Major Business
    • 7.14.3 MIKA MEDICAL Needle-free Injection Systems Product and Services
    • 7.14.4 MIKA MEDICAL Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.14.5 MIKA MEDICAL Recent Developments/Updates
    • 7.14.6 MIKA MEDICAL Competitive Strengths & Weaknesses
  • 7.15 Ferring Pharmaceuticals
    • 7.15.1 Ferring Pharmaceuticals Details
    • 7.15.2 Ferring Pharmaceuticals Major Business
    • 7.15.3 Ferring Pharmaceuticals Needle-free Injection Systems Product and Services
    • 7.15.4 Ferring Pharmaceuticals Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.15.5 Ferring Pharmaceuticals Recent Developments/Updates
    • 7.15.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.16 D'Antonio Consultants International
    • 7.16.1 D'Antonio Consultants International Details
    • 7.16.2 D'Antonio Consultants International Major Business
    • 7.16.3 D'Antonio Consultants International Needle-free Injection Systems Product and Services
    • 7.16.4 D'Antonio Consultants International Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.16.5 D'Antonio Consultants International Recent Developments/Updates
    • 7.16.6 D'Antonio Consultants International Competitive Strengths & Weaknesses
  • 7.17 Lepu Medical
    • 7.17.1 Lepu Medical Details
    • 7.17.2 Lepu Medical Major Business
    • 7.17.3 Lepu Medical Needle-free Injection Systems Product and Services
    • 7.17.4 Lepu Medical Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.17.5 Lepu Medical Recent Developments/Updates
    • 7.17.6 Lepu Medical Competitive Strengths & Weaknesses
  • 7.18 TECHiJET
    • 7.18.1 TECHiJET Details
    • 7.18.2 TECHiJET Major Business
    • 7.18.3 TECHiJET Needle-free Injection Systems Product and Services
    • 7.18.4 TECHiJET Needle-free Injection Systems Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.18.5 TECHiJET Recent Developments/Updates
    • 7.18.6 TECHiJET Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Needle-free Injection Systems Industry Chain
  • 8.2 Needle-free Injection Systems Upstream Analysis
    • 8.2.1 Needle-free Injection Systems Core Raw Materials
    • 8.2.2 Main Manufacturers of Needle-free Injection Systems Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Needle-free Injection Systems Production Mode
  • 8.6 Needle-free Injection Systems Procurement Model
  • 8.7 Needle-free Injection Systems Industry Sales Model and Sales Channels
    • 8.7.1 Needle-free Injection Systems Sales Model
    • 8.7.2 Needle-free Injection Systems Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Needle-free Injection Systems. Industry analysis & Market Report on Needle-free Injection Systems is a syndicated market report, published as Global Needle-free Injection Systems Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Needle-free Injection Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,480.00
    $6,720.00
    $8,960.00
    3,463.04
    5,194.56
    6,926.08
    4,170.88
    6,256.32
    8,341.76
    684,051.20
    1,026,076.80
    1,368,102.40
    378,112.00
    567,168.00
    756,224.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report